Effects of heparin lock-antibiotics to prevent infections in patients undergoing hemodialysis: A clinical trial

Journal of Mazandaran University of Medical Sciences

Volumn 22, Issue 96, 2013, Pages 99-104

  Shirzad, Mahboobeh ^a   Espahbodi, Fatemeh ^a   Baboli, Mozhgan Teymurzadeh ^a   Samakoosh, Mohammad Abedi ^a   Khalilian, Alireza ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibiotic heparin lock; Hemodialysis; Infection

Indexed keywords

CEFAZOLIN; HEPARIN;

ADULT; ARTICLE; CATHETER INFECTION; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE BLIND PROCEDURE;

EID: 84940356568     PISSN: 17359279     EISSN: 17359260     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Allon M. Dialysis catheter-related bacteremia: Treatment and prophylaxis. Am Jour Kidney Dis 2004; 44(5): 779-791.
2. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997; 127(4): 275-280.
3. Mokrzicki MH, Schroppel B, Von Gresdroff G, Rush H, Zdunek MP, Feingold R. Tunneled-cuffed catheter associated infections in hemodialysis patients who are seropositive for the human immunodeficiency virys. J Am Soc Nephrol 200; 11(11): 2122-2127.
4. Tanriover B, Carlton D, Saddekni S, Hamrick K, Oser R, Westfall AO, et al: Bacteremia associated with tunneled dialysis catheters: Comparison of two treatment strategies. Kidney Int 2000; 57(5): 2151-2155.
5. Beathard GA. Catheter management protocol for catheter related bacteremia prophylaxis. Semin Dial 2003; 16(5): 403-405.
6. Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, et al: A randomized controlled trial of tropical exit site mupirocin application in patients with tunneled cuffed hemodialysis catheters. Nephrol Dial Transplant 2002; 17(10): 1802-1807.
7. Lock CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with Polysporin ointment. J Am Soc Nephrol 2003; 14(1): 169-179.
8. Bambauer R, Mestres P, Pirrung KJ, Sioshansi P. Scanning electron microscopic investigation of catheters for blood access. Artif Organs. 1994; 18(4): 272-275.
9. Trerotola SO, Johnson MS, Sha H, Kraus MA, McKusky MA, Ambrosius WT, et al. Tunneled hemodialysis catheters: Use of a silver coated catheter for prevention of infection-A randomized study. Radiology 1998; 207(2): 491-496.
10. Kim SH, Song KI, Chang JW, Kim SB, Sung SA, Jo SK, et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int 2006; 69(1): 161-164.
11. Saxena AK, Panhotra BR, Al-hafiz AA, Sundaram DS, Abu-Oyun B, Al Mulhim K. Cefotaxime-heparin lock prophylaxis against hemodialysis catheter-related sepsis among Staphylococcus aureus nasal carriers. Saudi J Kidney Dis Transpl 2012; 23(4): 743-754.
12. Mortazavi M, Alsaeidi S, Sobhani R, Salimi F, Atapour A, Sharif N, et al. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaxime. J Res Med Sci 2011; 16(3): 303-309.
13. Chiou PF, Chang CC, Wen YK, Yang Y. Antibiotic lock technique reduces the incidence of temporary catheter-related infections. Clin Nephrol 2006; 65(6): 419-422.
14. Silva J, Antunes J, Carvalho T, Ponce P. Efficacy of preventing hemodialysis catheter infections with citrate lock. Hemodial Int 2012; 16(4): 545-552.
15. Bastani B, Minton J, Islam S. Insufficient penetration of systemic vancomycin into the Perm Cath lumen. Nephrol Dial Transplant 2000; 15(7):1035-1037.
16. Krishna Sami Z, Carlton D, Bimbo L, Taylor ME, Balkovetz DF, Barker J, et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002; 61(3): 1136-1142.